SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Lifeline Drugs & Pharma approves issue of shares

28 Aug 2012 Evaluate
Lifeline Drugs & Pharma has informed that the board of directors of the company at its meeting held on August 28, 2012, has approved issue and allotment up to 11,36,000 equity shares of face value of Rs. 10 each to non-promoters subject to the approval of shareholders in forthcoming EOGM. The price of issue of equity shares will be in accordance with the provisions of SEBI (Issue of Capital & Disclosure Requirement) Regulations, 2009 and the relevant date for the above purpose is August 24, 2012.

Further, the board will convene extra ordinary general meeting (EOGM) of the members of the company on September 25, 2012, seeking their approval for above businesses

The above information is a part of company's filings submitted to BSE.

Peers
Company Name CMP
Motilal Oswal Fin 757.10
Angel One 280.70
IIFL Capital Service 282.55
Nuvama Wealth 1296.30
Share India Sec. 143.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×